Drug
QRX-3
QRX-3 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
completed250%
not_yet_recruiting250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)
NCT07161843
completed
Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease
NCT07150338
completedphase_2
Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics
NCT06948292
not_yet_recruitingphase_2
Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
NCT06866236
Clinical Trials (4)
Showing 4 of 4 trials
NCT07161843Phase 2
Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)
NCT07150338
Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease
NCT06948292Phase 2
Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics
NCT06866236Phase 2
Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4